Study S001286

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05819853
Acronym: RESTORE
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 80
Start: 2023-11-03
Primary completion: 2028-02-01
Lead sponsor: University of Colorado, Denver
Conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries; Obese
Interventions: DRUG:Semaglutide Injectable Product (Wegovy and/or Ozempic)
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:R01HD108340

Registered primary outcomes

Change in ovulation frequency before and after semaglutide in females with PCOS [14 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.